Media stories about Concord Medical Services (NYSE:CCM) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Concord Medical Services earned a news sentiment score of 0.21 on Accern’s scale. Accern also gave media stories about the company an impact score of 44.0663374170016 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Concord Medical Services from a “sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. ValuEngine raised shares of Concord Medical Services from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd.
CCM stock traded down $0.03 during trading on Monday, reaching $3.38. The stock had a trading volume of 507 shares, compared to its average volume of 3,212. Concord Medical Services has a 1-year low of $2.46 and a 1-year high of $4.23. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.00 and a quick ratio of 1.00. The firm has a market capitalization of $147.87 million, a P/E ratio of -3.31 and a beta of 0.63.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
See Also: What does relative strength index mean?
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.